Plunkett Research Online: Torii Pharmaceutical

TORII PHARMACEUTICAL (TRXPF:PINX) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

TORII PHARMACEUTICAL CO LTD is engaged in the manufacturing and marketing of pharmaceutical products. Products of the firm include the injectable protease inhibitor FUTHAN, topical corticosteroid Antebate Ointment and Antebate Cream and uricosuric agent Urinorm tab. The firm’s sales and marketing .....



Torii Pharmaceutical
Ticker: TRXPF
Exchange: PINX
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 81 332316811
Fax:
Address: Torii Nihonbashi Buildingg, 4-1, Nihonbashi-Honcho
3-chome, Chuo-ku
Tokyo, 103-8439 Japan

Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceutical Preparation Manufacturing
ContactsDescription

TORII PHARMACEUTICAL CO LTD is engaged in the manufacturing and marketing of pharmaceutical products. Products of the firm include the injectable protease inhibitor FUTHAN, topical corticosteroid Antebate Ointment and Antebate Cream and uricosuric agent Urinorm tab. The firm’s sales and marketing .....See More See More

Auditor: Deloitte Touche Tohmatsu LLC
Legal Advisor:
$USD, In whole numbers,
except marked * or %
201620152014201420132012
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
Futhan
Stribild
Antebate Ointment
Antebate Cream
Urinorm
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: